INHALIERBARES MEDIKAMENT ENTHALTEND TIOTROPIUM

European patent · EP3143998 · Deleted

Register entry

Publication number
EP3143998
Application number
EP16185402
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Dec 6, 2012
Published
Mar 22, 2017
Granted
May 22, 2019
Deleted
Jun 19, 2024
Reason
Revoked in opposition
IPC classes
A61K 31/46 (2006.01)
A61K 9/00 (2006.01)
A61K 9/12 (2006.01)
A61P 11/00 (2006.01)
A61K 47/10 (2017.01)
A61K 47/12 (2006.01)
A61M 15/00 (2006.01)
Priority
US 201161577315 P 19.12.2011
GB 201200525 13.01.2012
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 19, 2024

    Change

    Published in Swissreg on 19.06.2024

  2. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  3. Jan 1, 2023

    Change

    Published in Swissreg on 01.01.2023

  4. Sep 22, 2021

    Change

    Published in Swissreg on 22.09.2021

  5. Feb 14, 2020

    Address changed

    Representative
    TR-IP Consulting LLC, Route de Coutset 18, 1485 Nuvilly → TR-IP Consulting LLC, Route du Coutset 18, 1485 Nuvilly

    Published in Swissreg on 14.02.2020

  6. Jun 12, 2019

    Agent entered

    Representative
    TR-IP Consulting LLC, Route de Coutset 18, 1485 Nuvilly

    Published in Swissreg on 12.06.2019

  7. May 22, 2019

    Granted

    Published in Swissreg on 22.05.2019

Parties

Holder

Teva Branded Pharmaceutical Products R & D, Inc.

41 Moores Road, Frazer, Pennsylvania 19355, US

Agent

TR-IP Consulting Sàrl

TR-IP Consulting LLC

Route du Coutset 18, 1485 Nuvilly

In liquidation

Inventor

ZENG, Xian-Ming

Miami, FL Florida 33169-5043, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.